Dartmouth Cancer Center is a clinical research site located in Lebanon, New Hampshire, United States 03756.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Dartmouth Cancer Center has participated in 8 clinical trials with 6 currently active.
Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL), Cancer.
Sponsors: Regeneron Pharmaceuticals, Dartmouth-Hitchcock Medical Center, BeiGene.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dartmouth Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dartmouth Cancer Center has 8 clinical trials on record, with 6 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL), Cancer.
Yes — Dartmouth Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.